No Detail Found!

Comparative efficacy of hydroxychloroquine and griseofulvin in the treatment of lichen planus.

Author(s)
Ishrat Bhuiyan Department of Dermatology & Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Ahammed Ali Department of Dermatology & Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Rahmatullah Siddique Department of Dermatology & Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Abdur Rob Hawlader Department of Dermatology & Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
M. A. Wahab Combined Military Hosptial (CMH), Dhaka, Bangladesh
Abida Sultana Department of Community Medicine, Rawalpindi Medical College, Rawalpindi, Pakistan
Nasrin Sultana Monamie Department of Dermatology & Venereology, BIHS Hospital, Darussalam, Mirpur, Dhaka, Bangladdesh
Abstract
Background Lichen planus (LP) is an unpredictable disease that typically persists for 1 to 2 years, but which may follow a chronic, relapsing course over many years. Management of LP can be challenging and discouraging for both the patient and physician. Objectives To compare the efficacy of hydroxychloroquine and griseofulvin in the treatment of LP. Patients and methods 80 cases of age group 20-60 years were selected for the study during the period of July 2007 to June 2009 in the Department of Dermatology and Venereology of three different hospitals in Bangladesh. All cases were diagnosed clinically and confirmed by histopathological examination of skin. The patients were randomly divided into 2 equal groups. Group A was given hydroxychloroquine 400 mg daily and group B was given griseofulvin 500mg daily for a period of 6 months. Results 53 (66%) male and 27 (34%) female were included in the study. The mean age in group A was 39.03±12.28 years and in group B was 42.87±11.16 years (p=0.146). The mean duration of the disease in group A was 4.37±3.87 months and in group B was 4.35±3.32 months (p=0.975). In group A clinical responders were 28 (70%): complete response in 7 (17.5%) and moderate improvement in 21 (52.5%) and in group B clinical responders were 17 (42.5%): complete response in 2 (5%) and moderate improvement in 15 (37.5%) [p=0.027]. Conclusion In this study both hydroxychloroquine and griseofulvin showed clinical improvement but hydroxychloroquine showed a relatively better response than griseofulvin in the treatment of LP
Publication Details
Page(s) 79-83
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 20, Issue: 2, Year: 2010

Request the full text from PASTIC

0

Citations

0

Downloads

56

Views